CA2448146A1 - Proteines secretees - Google Patents

Proteines secretees Download PDF

Info

Publication number
CA2448146A1
CA2448146A1 CA002448146A CA2448146A CA2448146A1 CA 2448146 A1 CA2448146 A1 CA 2448146A1 CA 002448146 A CA002448146 A CA 002448146A CA 2448146 A CA2448146 A CA 2448146A CA 2448146 A1 CA2448146 A1 CA 2448146A1
Authority
CA
Canada
Prior art keywords
polynucleotide
seq
polypeptide
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002448146A
Other languages
English (en)
Inventor
Henry Yue
Ernestine A. Lee
Shanya D. Becha
Mariah R. Baughn
Monique G. Yao
Y. Tom Tang
Janice K. Au-Young
Preeti G. Lal
Bridget A. Warren
Brendan M. Duggan
Uyen K. Tran
Yuming Xu
Kavitha Thangavelu
Thomas W. Richardson
Olga Bandman
Karen Anne Jones
Junming Yang
Brooke M. Emerling
Anita Swarnakar
Wen Luo
Narinder K. Chawla
Yalda Azimzai
Farrah A. Khan
Dyung Aina M. Lu
Jennifer A. Griffin
Soo Yeun Lee
Neil Burford
Vicki S. Elliott
Cynthia D. Honchell
Ann He
Patricia M. Mason
Joana X. Li
April J. A. Hafalia
Rajagopal Gururajan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of CA2448146A1 publication Critical patent/CA2448146A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des protéines sécrétées humaines (SECP) et des polynucléotides qui identifient et qui sont codants pour SECP. Cette invention concerne aussi des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Cette invention concerne enfin des techniques de diagnostic, de traitement ou de prévention de pathologies associées à l'expression aberrante de SECP.
CA002448146A 2001-05-25 2002-05-21 Proteines secretees Abandoned CA2448146A1 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US29372801P 2001-05-25 2001-05-25
US60/293,728 2001-05-25
US29701901P 2001-06-08 2001-06-08
US60/297,019 2001-06-08
US29929701P 2001-06-19 2001-06-19
US60/299,297 2001-06-19
US30053701P 2001-06-22 2001-06-22
US60/300,537 2001-06-22
US30193601P 2001-06-29 2001-06-29
US60/301,936 2001-06-29
US36243902P 2002-03-06 2002-03-06
US60/362,439 2002-03-06
US36364902P 2002-03-08 2002-03-08
US60/363,649 2002-03-08
US36604102P 2002-03-19 2002-03-19
US60/366,041 2002-03-19
PCT/US2002/016234 WO2002097035A2 (fr) 2001-05-25 2002-05-21 Proteines secretees

Publications (1)

Publication Number Publication Date
CA2448146A1 true CA2448146A1 (fr) 2002-12-05

Family

ID=27575351

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002448146A Abandoned CA2448146A1 (fr) 2001-05-25 2002-05-21 Proteines secretees

Country Status (4)

Country Link
EP (1) EP1578899A2 (fr)
JP (1) JP2005507239A (fr)
CA (1) CA2448146A1 (fr)
WO (1) WO2002097035A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093083A1 (fr) * 2004-03-29 2005-10-06 Kazuhisa Maeda Procédé pour la prédiction de maladies et procédé utilisant celui-ci
AU2013206613B2 (en) * 2005-09-12 2017-03-02 Biontech Ag Identification of tumor-associated antigens for diagnosis and therapy
EP1762575A1 (fr) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification d' antigènes associés aux tumeurs pour diagnose et thérapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518055B2 (en) * 2001-03-26 2003-02-11 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

Also Published As

Publication number Publication date
WO2002097035A3 (fr) 2007-08-23
JP2005507239A (ja) 2005-03-17
WO2002097035A2 (fr) 2002-12-05
EP1578899A2 (fr) 2005-09-28
AU2002303843A8 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
WO2002038602A2 (fr) Proteines secretees
EP1409535A2 (fr) Proteines secretees humaines
EP1299538A2 (fr) Proteines secretees
WO2003029437A2 (fr) Proteines secretees
US20030215822A1 (en) Secreted proteins
US20040248249A1 (en) Secreted proteins
US20040198651A1 (en) Secreted proteins
WO2002034783A2 (fr) Proteines transmembranaires
US20040018499A1 (en) Extracellular messengers
WO2002070669A2 (fr) Proteines secretees
WO2002026982A2 (fr) Proteines secretees
US20040063924A1 (en) Secreted proteins
CA2448146A1 (fr) Proteines secretees
US20070087342A1 (en) Secreted proteins
EP1409550A1 (fr) Messagers extracellulaires
CA2442062A1 (fr) Proteines secretees
US20040101930A1 (en) Secreted proteins
US20040087773A1 (en) Molecules for disease detection and treatment
US20040158039A1 (en) Secreted proteins
CA2434944A1 (fr) Proteines secretees
CA2446023A1 (fr) Proteines d'adhesion cellulaire et proteines de matrice extracellulaire
WO2004094589A2 (fr) Proteines secretees
WO2004007527A2 (fr) Proteines secretees
US20040115687A1 (en) Cell adhesion and extracellular matrix proteins
CA2431144A1 (fr) Proteines d'adhesion cellulaire

Legal Events

Date Code Title Description
FZDE Dead